The extracellular matrix as a multitasking player in disease

AD Theocharis, D Manou, NK Karamanos - The FEBS journal, 2019 - Wiley Online Library
Extracellular matrices (ECM s) are highly specialized and dynamic three‐dimensional (3D)
scaffolds into which cells reside in tissues. ECM is composed of a variety of fibrillar …

Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics

NK Karamanos, Z Piperigkou, AD Theocharis… - Chemical …, 2018 - ACS Publications
The extracellular matrix (ECM) constitutes a highly dynamic three-dimensional structural
network comprised of macromolecules, such as proteoglycans/glycosaminoglycans …

The extracellular matrix in breast cancer

J Insua-Rodríguez, T Oskarsson - Advanced drug delivery reviews, 2016 - Elsevier
The extracellular matrix (ECM) is increasingly recognized as an important regulator in breast
cancer. ECM in breast cancer development features numerous changes in composition and …

[HTML][HTML] Glycosaminoglycans and glycosaminoglycan mimetics in cancer and inflammation

S Morla - International journal of molecular sciences, 2019 - mdpi.com
Glycosaminoglycans (GAGs) are a class of biomolecules expressed virtually on all
mammalian cells and usually covalently attached to proteins, forming proteoglycans. They …

[HTML][HTML] Roles of proteoglycans and glycosaminoglycans in cancer development and progression

J Wei, M Hu, K Huang, S Lin, H Du - International journal of molecular …, 2020 - mdpi.com
The extracellular matrix (ECM) spatiotemporally controls cell fate; however, dysregulation of
ECM remodeling can lead to tumorigenesis and cancer development by providing favorable …

Glycosaminoglycans: key players in cancer cell biology and treatment

N Afratis, C Gialeli, D Nikitovic, T Tsegenidis… - The FEBS …, 2012 - Wiley Online Library
Glycosaminoglycans are natural heteropolysaccharides that are present in every
mammalian tissue. They are composed of repeating disaccharide units that consist of either …

[HTML][HTML] Targeting ECM disrupts cancer progression

FA Venning, L Wullkopf, JT Erler - Frontiers in oncology, 2015 - frontiersin.org
Metastatic complications are responsible for more than 90% of cancer-related deaths. The
progression from an isolated tumor to disseminated metastatic disease is a multistep …

Proteoglycans remodeling in cancer: Underlying molecular mechanisms

AD Theocharis, NK Karamanos - Matrix Biology, 2019 - Elsevier
Extracellular matrix is a highly dynamic macromolecular network. Proteoglycans are major
components of extracellular matrix playing key roles in its structural organization and cell …

Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting

AD Theocharis, SS Skandalis, GN Tzanakakis… - The FEBS …, 2010 - Wiley Online Library
The expression of proteoglycans (PGs), essential macromolecules of the tumor
microenvironment, is markedly altered during malignant transformation and tumor …

Microenvironmental regulation of epithelial–mesenchymal transitions in cancer

D Gao, LT Vahdat, S Wong, JC Chang, V Mittal - Cancer research, 2012 - AACR
The evolution of the cancer cell into a metastatic entity is the major cause of death in patients
with cancer. Activation of the epithelial-to-mesenchymal transition (EMT) endows invasive …